Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In Vivo

• Published in: Stem cell reports Vol. 12; no. 3; pp. 502 - 517
• Main Authors: Reinhardt, Lydia, Kordes, Susanne, Reinhardt, Peter, Glatza, Michael, Baumann, Matthias, Drexler, Hannes C.A., Menninger, Sascha, Zischinsky, Gunther, Eickhoff, Jan, Fröb, Claudia, Bhattarai, Prabesh, Arulmozhivarman, Guruchandar, Marrone, Lara, Janosch, Antje, Adachi, Kenjiro, Stehling, Martin, Anderson, Eric N., Abo-Rady, Masin, Bickle, Marc, Pandey, Udai Bhan, Reimer, Michell M., Kizil, Caghan, Schöler, Hans R., Nussbaumer, Peter, Klebl, Bert, Sterneckert, Jared L.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 05-03-2019; Elsevier
• Subjects: ALS; Alzheimer Disease - drug therapy; Alzheimer Disease - metabolism; Animals; CDK5; Cyclin-Dependent Kinase 5 - metabolism; Cytoskeleton - drug effects; Cytoskeleton - metabolism; Glycogen Synthase Kinase 3 beta - metabolism; GSK3β; Humans; induced pluripotent stem cells; Inflammation - drug therapy; Inflammation - metabolism; Microtubules - drug effects; Microtubules - metabolism; Nerve Degeneration - drug therapy; Nerve Degeneration - metabolism; Neurites - drug effects; Neurites - metabolism; neurodegeneration; neuroinflammation; Neurons - drug effects; Neurons - metabolism; Neuroprotective Agents - pharmacology; Phosphorylation - drug effects; Signal Transduction - drug effects; stem cell-based phenotypic screening; Zebrafish - metabolism; GSK3β; CDK5; neuroinflammation; neurodegeneration; ALS; induced pluripotent stem cells; stem cell-based phenotypic screening
• ISSN: 2213-6711; 2213-6711
• DOI: 10.1016/j.stemcr.2019.01.015

Neuroinflammation is a hallmark of neurological disorders and is accompanied by the production of neurotoxic agents such as nitric oxide. We used stem cell-based phenotypic screening and identified small molecules that directly protected neurons from neuroinflammation-induced degeneration. We demonstrate that inhibition of CDK5 is involved in, but not sufficient for, neuroprotection. Instead, additional inhibition of GSK3β is required to enhance the neuroprotective effects of CDK5 inhibition, which was confirmed using short hairpin RNA-mediated knockdown of CDK5 and GSK3β. Quantitative phosphoproteomics and high-content imaging demonstrate that neurite degeneration is mediated by aberrant phosphorylation of multiple microtubule-associated proteins. Finally, we show that our hit compound protects neurons in vivo in zebrafish models of motor neuron degeneration and Alzheimer's disease. Thus, we demonstrate an overlap of CDK5 and GSK3β in mediating the regulation of the neuronal cytoskeleton and that our hit compound LDC8 represents a promising starting point for neuroprotective drugs.
•Phenotypic screening identifies CDK inhibitors protecting neurons from inflammation•Inhibition of CDK5 is involved in neuroprotection but is not sufficient•Dual inhibition of CDK5 and GSK3β is neuroprotective in vitro and in vivo•Quantitative phosphoproteomics links neuroprotection to microtubule dynamics
Neuroinflammation is a hallmark of many neurological disorders and can be neurotoxic. Sterneckert and colleagues perform a phenotypic screening campaign identifying compounds protecting motor neurons from inflammation. Compound profiling demonstrates that dual inhibition of CDK5 and GSK3β mediates neuroprotection. Quantitative phosphoproteomics demonstrates that neuroprotection is linked to alterations in microtubule dynamics mediated by phosphorylation of microtubule-associated proteins.